MRE 2029F20
| SMILES | CCCn1c2nc([nH]c2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc2c(c1)OCO2 |
| InChIKey | DBWQRFKXNBVPGA-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 11 |
| Hydrogen bond donors | 2 |
| Rotatable bonds | 9 |
| Molecular weight (Da) | 509.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| A2B | AA2BR | Human | Adenosine | A | pKi | 8.26 | 8.26 | 8.26 | ChEMBL |
| A2B | AA2BR | Human | Adenosine | A | pKd | 8.78 | 8.78 | 8.78 | ChEMBL |
| A1 | AA1R | Human | Adenosine | A | pKi | 6.61 | 6.69 | 6.7 | ChEMBL |
| A1 | AA1R | Human | Adenosine | A | pKi | 6.7 | 6.7 | 6.7 | Guide to Pharmacology |
| A2A | AA2AR | Human | Adenosine | A | pKi | 8.26 | 8.26 | 8.26 | ChEMBL |
| A2A | AA2AR | Human | Adenosine | A | pKi | 6.0 | 6.0 | 6.0 | Guide to Pharmacology |
| A2B | AA2BR | Human | Adenosine | A | pKi | 8.26 | 8.38 | 8.5 | Guide to Pharmacology |
| A3 | AA3R | Human | Adenosine | A | pKi | 6.0 | 6.0 | 6.0 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| A2B | AA2BR | Human | Adenosine | A | pIC50 | 7.42 | 7.42 | 7.42 | ChEMBL |